Senzar Asset Management’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Senzar Asset Management’s Portfolio NDRM Stock Details NDRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-357,400	Closed	-$10.7M	–	40
2017 Q2	$10.7M	Buy	357,400 +33,700	+10%	+$873K	2.63%	13
2017 Q1	$8.59M	Buy	323,700 +136,900	+73%	+$3.39M	2.18%	15
2016 Q4	$4.15M	Buy	186,800 +15,500	+9%	+$290K	1.1%	21
2016 Q3	$3.17M	Sell	171,300 -24,500	-13%	-$425K	0.82%	32
2016 Q2	$3.18M	Sell	195,800 -19,600	-9%	-$330K	0.69%	35
2016 Q1	$3.04M	Buy	215,400 +13,700	+7%	+$185K	0.6%	32
2015 Q4	$3.44M	Buy	201,700 +145,700	+260%	+$2.84M	0.38%	39
2015 Q3	$1.16M	Buy	+56,000	New	+$1.15M	0.17%	35

Other funds holding NDRM

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

SAM

Sandell Asset Management New York $179M AUM 65.55% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

CFIC

City Financial Investment Company London, United Kingdom $562M AUM 5.93% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Senzar Asset Management's NDRM Position: Q3 2017 in Review

Senzar Asset Management sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q3 2017, closing a stake of 357,400 shares — an estimated $10.7M sold.

Senzar Asset Management first reported a position in NDRM in Q3 2015 and held it in 8 quarters. The position peaked at $10.7M in Q2 2017. 81 funds tracked by Wall St. Rank hold NDRM as of Q3 2017.

Senzar Asset Management reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q3 2017 after selling out during the quarter.
Senzar Asset Management sold 357,400 NeuroDerm Ltd. Ordinary Shares shares in Q3 2017, an estimated $10.7M.
Senzar Asset Management first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2015 and held it in 8 quarters.
Senzar Asset Management's NeuroDerm Ltd. Ordinary Shares position peaked at $10.7M in Q2 2017.
81 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q3 2017.

Based on Senzar Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.